We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
+7.32%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.65B
AUM Growth
–
Cap. Flow
+$1.64B
Cap. Flow
% of AUM
99.42%
Top 10 Holdings %
Top 10 Hldgs %
51.69%
Holding
47
New
47
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
+$200M |
| 2 |
Gilead Sciences
GILD
|
+$109M |
| 3 |
Intuitive Surgical
ISRG
|
+$91.7M |
| 4 |
ARTC
ARTHROCARE CORP
ARTC
|
+$77.4M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
+$67.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 70.8% |
| 2 | Financials | 4.43% |
| 3 | Consumer Staples | 3.77% |
| 4 | Technology | 0.79% |
| 5 | Real Estate | 0.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1
DELISTED
Veradigm Inc. Common Stock
MDRX
| $193M | 11.66% |
+14,900,000
| New | +$200M |
|
|
2
Gilead Sciences
GILD
$162B
| $108M | 6.51% |
+2,100,000
| New | +$109M |
|
|
3
Intuitive Surgical
ISRG
$127B
| $93.6M | 5.66% |
+1,665,000
| New | +$91.7M |
|
|
ARTC
4
DELISTED
ARTHROCARE CORP
ARTC
| $77.7M | 4.7% |
+2,250,000
| New | +$77.4M |
|
|
WMGI
5
DELISTED
Wright Medical Group Inc
WMGI
| $72.7M | 4.4% |
+2,775,000
| New | +$67.5M |
|
6
Viatris
VTRS
$20.4B
| $65.9M | 3.99% |
+2,125,000
| New | +$63.5M |
|
7
Biogen
BIIB
$30B
| $64.6M | 3.9% |
+300,000
| New | +$64.1M |
|
8
Vertex Pharmaceuticals
VRTX
$121B
| $62M | 3.75% |
+775,000
| New | +$57.1M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
| $60M | 3.63% |
+650,000
| New | +$62.6M |
|
|
CBST
10
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $57.9M | 3.5% |
+1,200,000
| New | +$59M |
|
|
MDCO
11
DELISTED
Medicines Co
MDCO
| $51.5M | 3.12% |
+1,675,000
| New | +$56M |
|
12
eHealth
EHTH
$42.2M
| $51.2M | 3.09% |
+2,252,119
| New | +$50.6M |
|
|
CFN
13
DELISTED
CAREFUSION CORPORATION
CFN
| $49.7M | 3.01% |
+1,350,000
| New | +$47.7M |
|
14
Nektar Therapeutics
NKTR
$2.39B
| $46.2M | 2.79% |
+266,667
| New | +$40.9M |
|
15
Tenet Healthcare
THC
$20.5B
| $46.1M | 2.79% |
+1,000,000
| New | +$44.8M |
|
16
Monster Beverage
MNST
$94.3B
| $45.6M | 2.76% |
+4,500,000
| New | +$42.3M |
|
|
NUVA
17
DELISTED
NuVasive, Inc.
NUVA
| $35.9M | 2.17% |
+1,450,000
| New | +$31.7M |
|
|
MDVN
18
DELISTED
MEDIVATION, INC.
MDVN
| $32M | 1.93% |
+1,300,000
| New | +$32.7M |
|
19
Community Health Systems
CYH
$393M
| $30.5M | 1.84% |
+786,500
| New | +$29.6M |
|
|
ITMN
20
DELISTED
INTERMUNE INC
ITMN
| $29.8M | 1.8% |
+3,100,000
| New | +$29.6M |
|
21
HCA Healthcare
HCA
$87.2B
| $28.8M | 1.74% |
+800,000
| New | +$30.9M |
|
22
Molina Healthcare
MOH
$10.2B
| $27M | 1.63% |
+725,000
| New | +$25.6M |
|
|
SHPG
23
DELISTED
Shire pic
SHPG
| $26.2M | 1.58% |
+275,000
| New | +$25.8M |
|
|
CTRX
24
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $25.6M | 1.55% |
+525,000
| New | +$27.4M |
|
25
Alkermes
ALKS
$8.22B
| $23.7M | 1.43% |
+825,000
| New | +$24M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for HealthCor Management, which disclosed 47 positions worth $1.65B. Its ten largest holdings account for 52% of the portfolio.
Its largest position is Veradigm Inc. Common Stock: 14,900,000 shares worth $193M.
By sector, the portfolio is most concentrated in Healthcare at 71% of assets, followed by Financials and Consumer Staples.
- HealthCor Management's largest Q2 2013 buy was Veradigm Inc. Common Stock: 14,900,000 shares worth $193M.
- HealthCor Management's ten largest holdings make up 52% of its $1.65B portfolio in Q2 2013.
- HealthCor Management disclosed 47 positions in Q2 2013, its first 13F filing on record.
Based on HealthCor Management's 13F filing for Q2 2013, filed 14 Aug 2013.